Finding potential cancer drugs was a new way to develop therapy after the discovery of science.
Researchers have developed a potential drug to choose two ways of tumor cells.
Their research aims at identifying the preparations that are prone to protein in protein cells known as telomerase.
Scientists hope that identification of drugs not only hinders this protein but also divides cancer cells when cancer cells divide their DNA-chromosomes – to create new cells.
Attack on two front fronts can prevent cancer cells and, therefore, killings.
The researchers use fluorescent markers studied by artificial human chromosomes in the University of Edinburgh at the Paris Institute, the US National Cancer Institute and the DNA Institute of Japanese Causes.
This allowed the team to easily identify when and how often the chromosomes were treated.
The drugs identified in this way have been investigated in different types of cancer cells, to investigate exactly how the chromosome has been able to highlight a high rate of division.
The researchers expressed their hope that newly-occurring drugs help develop more effective treatment.
Research published Cancer research, Wellcome Well, at the National Institutes of Health and the Japanese Government.
Professor William C. Jensko of the University of Edinburgh University of Biology School participated in the study: "Our approach allows the selection of narcotic drugs that regulate the normal cell of cancer cells, hopefully it can develop more effective therapy aimed at tumors."
Dr Mar Carmena, the School of Biological Sciences at Edberg University, who also participated in the study, said: "We hope that our bilateral approach may be useful in using newly-selected, more effective drugs.
Materials provided Edinburgh University. Note: Edit content for style and length.